• 中国科技论文统计源期刊
  • 中国科技核心期刊
  • 中国高校优秀期刊
  • 安徽省优秀科技期刊

留言板

尊敬的读者、作者、审稿人, 关于本刊的投稿、审稿、编辑和出版的任何问题, 您可以本页添加留言。我们将尽快给您答复。谢谢您的支持!

姓名
邮箱
手机号码
标题
留言内容
验证码

NKX2.5基因在先天性心脏病中的研究进展

尹成果 刘学刚

引用本文:
Citation:

NKX2.5基因在先天性心脏病中的研究进展

    作者简介: 尹成果(1985-),男,硕士研究生.
  • 中图分类号: R541.1

  • [1] Clark KL,Yutzey KE,Benson DW.Transcription factors and congenital heart defects[J].Annu Rev Physiol,2006,68:97-121.
    [2] Ransom J,Srivastava D.The genetics of cardiac birth defects[J].Semin Cell Dev Biol,2007,18(1):132-139.
    [3] Pang S,Shan J,Qiao Y,et al.Genetic and functional analysis of the nkx 2.5 gene promoter in patients with ventricular septal defects[J].Pediatr Cardiol,2012,33(8):1355-1361.
    [4] Satoda M,ZhaoF,Diaz GA,et al.Mutations in TFAP2B cause Char syndrome,familial form of patent ductus arteriosus[J].Nat Genet,2000,25(1):42-46.
    [5] Karkera JD,Lee JS,Roessler E,et al.Loss-of-function mutations in growth differentiation factor-l(GDF1) are associated with congenital heart defects in humans[J].Am J Hum Genet,2007,81(5):987-994.
    [6] Wang B,Yan J,Mi R,et al.Forkhead box Hl(FOXH1)sequence variants in ventricular septal defect[J].Int J Cardiol,2010,145(1):83-85.
    [7] Salazar M,Consoli F,Villegas V,et al.Search of somatic GATA4 and NKX2.5 gene mutations in sporadic septal heart defects[J].Eur J Med Genet,2011,54(3):306-309.
    [8] Terada R,Warren S,Lu JT,et al.Ablation of Nkx2-5 at mid-embryonic stage results in premature lethality and cardiac malformation[J].Cardiovasc Res,2011,91(2):289-299.
    [9] Sizarov A,Devalla HD,Anderson RH,et al.Molecular analysis of patterning of conduction tissues in the developing human heart[J].Circ Arrhythm Electrophysiol,2011,4(4):532-542.
    [10] 陈轶维,赵武,李奋,等.单纯性动脉导管未闭患儿TFAP-2B基因单核苷酸多态性分析[J].上海交通大学学报,2011,31(9):1240-1244.
    [11] Vianna CB,Miura N,Pereira AC,et al.Holt-Oram syndrome:novel TBX5 mutation and associated anomalous right coronary artery[J].Cardiol Young,2011,21(3):351-353.
    [12] Takeuchi JK,Lou X,Alexander JM,et al.Chromatin remodelling complex dosage modulates transcription factor function in heart development[J].Nat Commun,2011,2:187.
    [13] Martin LK,Mezentseva NV,Bratoeva M,et al.Canonical WNT signaling enhances stem cell expression in the developing heartwithout a corresponding inhibition of cardiogenic differentiation[J].Stem Cells Dev,2011,20(11):1973-1983.
    [14] Moskowitz IP,Wang J,Peterson MA,et al.Transcription factor genes Smad4 and Gata4 cooperatively regulate cardiac valve development[J].Proc Natl Acad Sci USA,2011,108(10):4006-4011.
    [15] Peng T,Wang L,Zhou SF,et al.Mutations of the GATA4 and NKX2.5 genes in Chinese pediatric patients with non-familial congenital heart disease[J].Genetica,2010,138(11/12):1231-1240.
    [16] Butler TL,Esposito G,Blue GM,et al.GATA4 mutations in 357 unrelated patients with congenital heart malformation[J].Genet Test Mol Biomarkers,2010,14(6):797-802.
    [17] Maitra M,Schluterman MK,Nichols HA,et al.Interaction of Gata4 and Gata6 with Tbx5 is critical for normal cardiac development[J].Dev Biol,2009,326(2):368-377.
    [18] Bodmer R.The gene tinman is required for specification of the heart and visceral muscles in Drosophila[J].Development,1993,118(3):719-729.
    [19] Turbay D,Wechsler SB,Blanchard KM,et al.Molecular cloning,chromosomal mapping,and characterization of the human cardiac-specific homeobox gene hCsx[J].MolMed,1996,2(1):86-96.
    [20] Schott JJ,Benson DW,Basson CT,et al.Congenital heart disease caused by mutations in the transcription factor Nkx 2.5[J].Science,1998,281(5373):108-111.
    [21] Bartlett H,Sutherland L,Kolker S,et al.Transient early embryonic expression of Nkx2.5 mutations linked to congenital heart defects in human causes heart defects in Xenopus laevis[J].Dev Dyn,2007,236(9):2475-2484.
    [22] Kasahara H,Bartunkova S,Schinke M,et al.Cardiac and extracardiac Expression of Csx/Nkx2.5 Homeodomain Protein[J].Circ Res,1998,82(9):936-946.
    [23] Lyons I,Parsons LM,Hartley L,et al.Myogenic and morphogenetic defects in the heart tubes of murlne embryos lacking the homeo box gene Nkx2.5[J].Gene Dev,1995,9(13):1654-1666.
    [24] Akazawa H,Komuro I.Cardiac transcription factor CSx/Nkx2.5:Its role in cardiac development and diseases[J].Pharmacol Ther,2005,107(2):252-268.
    [25] Groot AG,Bartelings M,Deruiter M,et al.Basics of cardiac development for the understanding of congenital heart malformations[J].Pediatr Res,2005,57(2):169-176.
    [26] Meysen S,Marger L,Hewett KW,et al.Nkx2.5 cell-autonomous gene function is required for the postnatal formation of the peripheral ventricular conduction system[J].Dev Biol,2007,303(2):740-753.
    [27] Pashmforoush M,Lu JT,Chen H,et al.Nkx2.5 pathways and congenital heart disease:loss of ventricular myocyte lineage specification leads to progressive cardiomyopathy and complete heart block[J].Cell,2004,117(3):373-386.
    [28] Zou Y,Evans S,Chen J,et al.CARP,a cardiac ankyrin repeat protein,is downstream in the Nkx2.5 homeobox gene pathway[J].Development,1997,124(4):793-804.
    [29] Kiewitz R,Lyons GE,Schafer BW,et al.Transcriptional regulation of S100A1 and expression during mouse heart development[J].Biochim Biophys Acta,2000,1498(2/3):207-219.
    [30] Willingham-Rocky LA,Golding MC,Wright JM,et al.Cloning of GJA1(connexin43) and its expression in canine ovarian follicles throughout the estrous cycle[J].Gene Ex Pr Patterns,2007,7(1/2):66-71.
    [31] Wang J,Zhang H,Iyer D,et al.Regulation of cardiac specific Nkx2.5 gene activity by small ubiquitin-like modifier[J].J Biol Chem,2008,283(34):23235-23243.
    [32] Schott JJ,Benson DW,Basson CT,et al.Congenital heart disease caused by mutations in the transcription factor nkx 2.5[J].Science,1998,281(5373):108-111.
    [33] Benson DW,Silberbach GM,Kavanaugh-McHugh A,et al.Mutations in the cardiac transcription factor nkx2.5 affect diverse cardiac developmental pathways[J].J Clin Invest,1999,104(11):1567-1573.
    [34] Kasahara H,Lee B,Schott JJ,et al.Loss of function and inhibitory effects of human CSX/Nkx2.5 homeoprotein mutations associated with congenital heart disease[J].J Clin Invest,2000,106(2):299-308.
    [35] Goldmuntz E,Geiger E,Benson D.Nkx2.5 mutations in patients with tetralogy of Fallot[J].Circulation,2001,104(21):2565-2568.
    [36] McElhinney D,Geiger E,Blinder J,et al.Nkx2.5 mutations in patients with congenital heart disease[J].J Am Coll Cardiol,2003,42(9):1650-1655.
    [37] Reamon-Buettner SM,Hecker H,Spanel-Borowski K,et al.Novel Nkx2.5 mutations in diseased heart tissues of patients with cardiac malformations[J].Am J Pathol,2004,164(6):2117-2125.
    [38] Prall O,Elliott D,Harvey R.Developmental paradigms in heart disease:insights from tinman[J].Ann Med,2002,34(3):148-156.
    [39] 田莉,祝建芳,杨钧国,等.继发孔房间隔缺损一家系CSX/NKX2.5基因突变研究[J].中华医学杂志,2008,88(4):250-253.
    [40] 丁建东,方翔,李开如,等.转录因子Nkx2.5和GATA4的相互作用[J].中国组织工程研究,2012,16(11):1933-1936.
    [41] Granados-Riveron JT,Pope M,Bu'lock FA,et al.Combined mutation screening of NKX2.5,GATA4,and TBX5 in congenital heart disease:multiple heterozygosity and novel mutations[J].Congenit Heart Dis,2012,7(2):151-159.
    [42] Wang J,Xin YF,Liu XY,et al.A novel NKX2.5 mutation in familial ventricular septal defect[J].Int J Mol Med,2011,27(3):369-375.
  • [1] 王安生刘学刚 . 肺血减少型先天性心脏病远端肺血管发育不良的病理学研究现状. 蚌埠医学院学报, 2010, 35(4): 432-433.
    [2] 王康武刘学刚 . 肺血减少型先天性心脏病远端肺血管发育与血清VEGF、bFGF表达水平的相关性研究进展. 蚌埠医学院学报, 2009, 34(11): 1042-1044.
    [3] 高峰 . 食管癌研究现状综述. 蚌埠医学院学报, 2010, 35(6): 645-648.
    [4] 周彤陆洪俊 . 蒽环类药物心脏毒性的监测及研究进展. 蚌埠医学院学报, 2004, 29(4): 373-375.
    [5] 高健萱张恒 . 经导管主动脉瓣置入术治疗老年退行性心脏瓣膜病研究进展. 蚌埠医学院学报, 2019, 44(2): 279-281. doi: 10.13898/j.cnki.issn.1000-2200.2019.02.041
    [6] 余克辉马辉叶斌 . 高频超声在先天性肌性斜颈诊疗中的应用研究进展. 蚌埠医学院学报, 2018, 43(9): 1254-1256. doi: 10.13898/j.cnki.issn.1000-2200.2018.09.039
    [7] 刘婷婷 . 整合子-基因盒系统在细菌耐药性中的作用. 蚌埠医学院学报, 2006, 31(2): 215-217.
    [8] 栾文斌项平 . 视网膜干细胞相关基因的研究进展. 蚌埠医学院学报, 2012, 36(11): 1402-1405.
    [9] 张庆顾琴龙 . 胃癌转移的相关基因研究进展. 蚌埠医学院学报, 2008, 33(6): 691-693.
    [10] 甘怀勇 . 胶质瘤抑癌基因的研究进展. 蚌埠医学院学报, 2005, 30(3): 275-277.
    [11] 张思铭陈汉杨柳刘梅 . SASH1基因在肿瘤研究中的进展. 蚌埠医学院学报, 2021, 46(5): 699-701. doi: 10.13898/j.cnki.issn.1000-2200.2021.05.035
    [12] 吴学森 . 基于全基因组关联分析的基因(环境)交互作用统计学方法进展. 蚌埠医学院学报, 2008, 33(6): 706-709.
    [13] 张发良闵大六 . CYP3A基因在肿瘤中的研究进展. 蚌埠医学院学报, 2011, 36(2): 201-204.
    [14] 张莉石建华项平 . KCNQ1基因与2型糖尿病发病关系的研究进展. 蚌埠医学院学报, 2010, 35(5): 539-541.
    [15] 钱军 . 基因测序在肿瘤精准治疗中应用研究进展. 蚌埠医学院学报, 2018, 43(10): 1298-1300. doi: 10.13898/j.cnki.issn.1000-2200.2018.10.008
    [16] 廖亚平鲍明升梁玉华 . 叶酸代谢相关基因多态性与Down综合征发生的关系. 蚌埠医学院学报, 2009, 34(10): 949-951.
    [17] 殷发祥许培权 . 乳腺癌相关基因p16、PTEN、ATM的研究进展. 蚌埠医学院学报, 2016, 41(2): 276-278. doi: 10.13898/j.cnki.issn.1000-2200.2016.02.048
    [18] 郝海波许培权 . 抑癌基因p16与恶性肿瘤关系的研究进展. 蚌埠医学院学报, 2012, 36(3): 361-363.
    [19] 周燕江浩 . TIP30/CC3基因与肿瘤转移的研究进展. 蚌埠医学院学报, 2012, 36(7): 871-874.
    [20] 高洁陈昌杰 . 抑癌基因p16、p27与原发性肝癌关系的研究. 蚌埠医学院学报, 2012, 36(5): 613-615.
  • 加载中
计量
  • 文章访问数:  2138
  • HTML全文浏览量:  267
  • PDF下载量:  151
  • 被引次数: 0
出版历程
  • 收稿日期:  2013-09-24

NKX2.5基因在先天性心脏病中的研究进展

    作者简介: 尹成果(1985-),男,硕士研究生.
  • 蚌埠医学院第一附属医院胸心外科, 安徽蚌埠 233004
参考文献 (42)

目录

    /

    返回文章
    返回